REBEKAH LUCERO: Open Payments
NPI 1285295634 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,217 in 57 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $985 · 2025 $5,217
Travel & lodging: $3,503Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 27 | $4,538 |
| PFIZER INC. | 11 | $160 |
| Amgen Inc. | 3 | $108 |
| Kestra Medical Technology Services, Inc. | 2 | $97 |
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| Impulse Dynamics (USA) Inc. | 1 | $71 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: SYMPLICITY G3, LINQ II, VYNDAQEL, REPATHA, Assure WCD, LEQVIO, Optimizer, ELIQUIS.
Industry payments across ID — which companies pay providers there.
